当前时代婴幼儿ABO血型不合心脏移植登记实践与结局分析
基于儿科心脏移植学会登记数据,比较2010至2018年2岁以下儿童ABO血型不合(ABOi)与相容(ABOc)登记的变化及结局。ABOi登记比例从49%升至72%,ABOi登记者年龄更小、先天性心脏病比例更高、机械通气和高紧急状态更多,但移植后生存相似;O型血ABOi登记等待时间更短。
要点
- 2岁以下儿童ABOi心脏移植登记已成为多数中心的常规实践。
- ABOi登记者风险 profile 更高但移植后生存与ABOc相似。
- O型血ABOi登记可显著缩短等待移植时间。
核心结论
- 当前时代多数2岁以下儿童初次登记即接受ABOi心脏移植,尤其O型血等待时间更短,移植后生存相似。
研究设计与样本
- 基于儿科心脏移植学会登记的回顾性队列研究,纳入2010年1月至2018年6月登记的2039例2岁以下儿童,比较ABOi与ABOc登记,并对O型血受者进行亚组分析。
主要发现
- ABOi登记比例从2010年的49%显著上升至2017年的72%。
- ABOi登记患者年龄和体表面积更低,先天性心脏病、机械通气和高紧急状态比例更高(均p<0.01),机械循环支持使用两组相似。
- 1288例接受移植的患者中239例(18.6%)接受了ABOi器官,每年比例15%-40%。
- 等待期死亡、移出等待名单和等待期生存两组相似;O型血ABOi登记等待移植时间显著更短(p<0.02),全血型组接近显著(p=0.057)。
- 移植后生存相似,但ABOc登记却接受ABOi器官的患者生存更低,这些患者在等待期间机械循环支持需求和高紧急状态登记增加。
临床怎么用
- 对于2岁以下需要心脏移植的儿童,可考虑初次登记为ABOi以缩短等待时间,尤其O型血患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart transplantation from ABO incompatible (ABOi) donors has evolved into a progressively accepted therapy in young children. We assessed the recent practice of ABOi listing impact on waitlist and post-transplant outcomes. METHODS: Using the Pediatric Heart Transplant Society registry, we compared clinical presentation, waitlist parameters, and post-transplant survival of children < 2 years of age listed for ABOi vs ABO compatible (ABOc) heart transplant between January 2010 and June 2018 with sub-analysis of blood group O recipients. RESULTS: Among 2,039 patients, ABOi listing increased significantly with time from 49% (2010) to 72% (2017). ABOi-listed patients had lower age and body surface area, and higher proportion of congenital heart disease, mechanical ventilation, and high urgency status (all p < 0.01). Use of mechanical circulatory support was similar between groups. Of 1,288 patients reaching transplant, 239 (18.6%) received an ABOi organ (15%-40%/year). Death while waiting, removal from the waitlist, and waitlist survival were similar between groups. Time to transplant was significantly shorter for ABOi listing in blood group O patients (p < 0.02), approaching significance (p = 0.057) for all blood groups. Post-transplant survival was similar except for lower survival of patients listed ABOc but transplanted ABOi. These patients showed increasing need for mechanical circulatory support and high urgency listing while waiting. CONCLUSIONS: In the current era, primary listing for ABOi heart transplant has become routine for the majority of children < 2 years old, resulting in shorter waitlist time, especially in blood group O. Post-transplant survival is similar despite ABOi-listed children still showing a higher risk profile.
引用
- Urschel S, McCoy M, Cantor RS, et al. A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation. J Heart Lung Transplant. 2020. PMID: 32201088. doi:10.1016/j.healun.2020.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。